T1	SNP 23 31	rs570613
T2	Entity 17 22	GATA3
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
T3	Neg 0 2	No
T5	Spec 3 11	evidence
T4	Association 59 63	risk
E1	Association:T4 bc:T6 snp_int:T1
T6	Cancer 45 58	breast cancer
R2	Negation_marker Arg1:E1 Arg2:T3	
R3	Speculation_marker Arg1:E1 Arg2:T5	
T7	Entity 66 88	GATA-binding protein 3
R4	Equiv Arg1:T2 Arg2:T7	
T8	SNP 275 283	rs570613
T9	Entity 324 332	intron 4
A1	SNP_Type T1 Non-Coding
A2	SNP_Type T8 Non-Coding
T10	Entity 336 341	GATA3
R5	SNP_coupled_gene Arg1:T8 Arg2:T10	
R6	SNP_location Arg1:T8 Arg2:T9	
T11	Association 414 418	risk
E2	Association:T11 snp_int:T8
A3	Effect_Type E2 Decrease
T12	Effect_Type 387 396	reduction
R7	Effect_type_marker Arg1:E2 Arg2:T12	
T13	Cancer 400 413	breast cancer
T14	Entity 531 537	Norway
T15	Entity 542 548	Poland
R8	Population_assignment Arg1:T8 Arg2:T14	
R9	Population_assignment Arg1:T8 Arg2:T15	
T16	Spec 575 588	some evidence
T17	Level 595 603	stronger
T18	Association 604 615	association
E3	Association:T18 snp_int:T8 bc:T21
A4	Level E3 High
R10	Level_marker Arg1:E3 Arg2:T17	
R11	Speculation_marker Arg1:E3 Arg2:T16	
T19	Entity 621 638	estrogen receptor
T20	Entity 640 642	ER
T21	Cancer 621 638;644 660	estrogen receptor negative tumours
R12	Equiv Arg1:T20 Arg2:T19	
T22	Neg 644 652	negative
T23	Organic_inorganic_molecules_affected 604 615	association
E4	Organic_inorganic_molecules_affected:T23 Theme:T19 Agent:T8
R13	Negation_marker Arg1:E4 Arg2:T22	
T24	Entity 753 758	GATA3
T25	SNP 759 767	rs570613
R14	SNP_coupled_gene Arg1:T25 Arg2:T24	
T26	Spec 963 968	found
T27	Neg 969 971	no
T28	Association 972 983	association
E5	Association:T28 bc:T30 snp_int:T29 bc2:T31 snp_int2:T32
R15	Negation_marker Arg1:E5 Arg2:T27	
R16	Speculation_marker Arg1:E5 Arg2:T26	
T29	SNP 992 1000	this SNP
R17	Equiv Arg1:T29 Arg2:T25	
T30	Cancer 1005 1018	breast cancer
T31	Cancer 1092 1103	ER negative
A5	Cancer_Type T31 ER-
A6	Cancer_Type T21 ER-
T32	SNP 992 1000	this SNP
R18	Equiv Arg1:T32 Arg2:T25	
T33	Entity 1161 1175	BRCA1 mutation
R19	Risk_Factor Arg1:T32 Arg2:T33	
T34	Entity 1229 1243	BRCA2 mutation
R20	Risk_Factor Arg1:T32 Arg2:T34	
T35	Neg 1322 1324	no
T36	Spec 1325 1333	evidence
T37	Entity 1346 1351	GATA3
T38	SNP 1352 1360	rs570613
R21	SNP_coupled_gene Arg1:T38 Arg2:T37	
T39	Level 1380 1386	strong
T40	Interaction 1387 1409	linkage disequilibrium
E6	Interaction:T40 Entity:T41 Entity2:T38
A7	Level E6 High
R22	Level_marker Arg1:E6 Arg2:T39	
T41	SNP 1365 1376	any variant
T42	Entity 1460 1465	women
R23	Population_assignment Arg1:E6 Arg2:T42	
R24	Population_assignment Arg1:T38 Arg2:T42	
R25	Population_assignment Arg1:T25 Arg2:T42	
T43	Association 1422 1432	associated
E7	Association:T43 bc:T44 snp_int:E6 snp_int2:T38
T44	Cancer 1438 1451	breast cancer
R26	Negation_marker Arg1:E7 Arg2:T35	
R27	Speculation_marker Arg1:E7 Arg2:T36	
A8	SNP_Type T25 Non-Coding
A9	SNP_Type T38 Non-Coding
